Wednesday, February 5, 2025

Marc ZERBOLA CHALLANDE

193 POSTS
Marc has been involved in the Stock Market Media Industry for the last +5 years. After obtaining a college degree in engineering in France, he moved to Canada, where he created Money,eh?, a personal finance website.

Exclusive articles:

Holiday Financial Cheer: Navigating the Season with Savvy Investments

As the holiday season wraps the world in its festive glow, it’s the perfect time to reflect on financial goals and explore opportunities that...

5 Quantum Computing Stocks to Look After

Quantum computing is rapidly emerging as one of the most transformative technologies of the 21st century. With its potential to solve complex problems far...

Quantum Computing Skyrocketed, Who’s Next? 

Quantum Computing Inc. (QUBT) has taken the market by storm, with its stock soaring after a game-changing contract with NASA. This explosive growth highlights...

APRE vs. KPTI: Which Stock is the Best Choice? 

Aprea Therapeutics, Inc. (NASDAQ: APRE) and Karyopharm Therapeutics Inc. (NASDAQ: KPTI) are both clinical-stage biopharmaceutical companies specializing in oncology, each with unique therapeutic approaches...

Stocks to Watch Today on 12/19

Dollar Tree's Leadership Shake-Up Dollar Tree is undergoing a major leadership shift as the company announced that Executive Chairman Richard Dreiling would temporarily take on...

Breaking

NurExone: Pioneering Exosome Therapies for Vision and Spinal Cord Regeneration

NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the...

How the Uranium Market Will Be Impacted by Trump’s Policy

As global energy policies evolve, the uranium market is...

Why Markets Are Skittish About Trump’s Tariff Policy

In recent years, the announcement of new tariff policies...

NurExone Biologic Inc. and Its Competitors in Regenerative Medicine and Spinal Cord Injury Treatment

Regenerative medicine is revolutionizing the treatment of severe neurological...
spot_img